Ir para o conteúdo principal

Grafa News and Videos — Page 98

Destaques de Grafa

Grafa
Health

Summit Therapeutics highlights ivonescimab Phase III biliary tract cancer data

Summit Therapeutics (NASDAQ:SMMT) announced that data from the Phase III HARMONi-GI1 trial evaluating ivonescimab, a potential first-in-class investigational bispecific antibody, will be presented at the Presidential Symposium II during the European Society for Medical Oncology (ESMO) 2026 Congress.

Leia mais: Summit Therapeutics highlights ivonescimab Phase III biliary tract cancer data

GARANTA JÁ SEU GRAFA EDGE

Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas